Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples